TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in the 95th percentile of the norm of acceleration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in 10 Meters Walking Test (10MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Min Walking test (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: De novo mutation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reproductive, maternal, neonatal and child health services
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Total local anesthetic and opioid administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scalp Investigator Global Assessment (S-IGA) Score Change
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Body Investigator Global Assessment (B-IGA) Score Change
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Absolute Change in Total Atrophic Acne Scar Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percentage of patients achieving SALT≤20
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uptake of C-11 Pittsburgh compound-B (PiB) in white matter myelin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Uptake of C-11 ER176 Radiotracer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of treatment related deaths
Endpoint domain: Mortality/survival
Primary endpoint: Number of overall grade 3-4 acute Graft-Versus-Host-Disease (GVHD)
Endpoint domain: Adverse events/effects
Primary endpoint: App Usability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants With a Nonvertebral Fracture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Calf circumference measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and effectiveness of endoscopic ESD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: respiratory capacity indicators
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Quality of Life (OL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Glycated hemoglobin in %
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in subjective dry mouth score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GMTs of Prefusion F-protein (preF) Antibodies on Day 29
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: GMTs of Prefusion F-protein (preF) Antibodies on Day 57
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Amax parameter pharmacodynamics for anti-FXA marker
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ASCE0-t parameter pharmacodynamics for anti-FXA marker
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ASCE0-inf parameter pharmacodynamics for anti-FXA marker
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amax parameter pharmacodynamics for anti-FIIA marker
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ASCE0-t parameter pharmacodynamics for anti-FIIA marker
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Knee Society Score (KSS) at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change From Baseline in Oxford Knee Score (OKS) at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change From Baseline in Knee Injury and Osteoarthritis Outcome Score (KOOS) at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change From Baseline in Forgotten Joint Score Short Form (FJS-12) at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Impact of traumatic events
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Acceptance and action towards thoughts and feelings
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Quality of life in pediatric patients
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Feeding behavior assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression-free survival of 12 weeks
Endpoint domain: Mortality/survival
Primary endpoint: Organ volume change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exclusion of bacterial meningitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Biomarkers of Acute Kidney Injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change from Baseline Event-Related Rumination Inventory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from Baseline Cancer Fatigue Scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change from Baseline Connor-Davidson Resilience Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of Donor specific antibody (DSA) formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: COP Assessment Test Scale (CAT)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to deterioration (TTD)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Degree of severity of the clinical picture of COVID-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerability of Intervention
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Mean Systolic Blood Pressure (SBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Overall agreement between image quality classification and data tagging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of exams with at least Medium image quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of clinically interpretable cases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bronchoalveolar lavage fluid pepsin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incremental cost-utility ratio (ICUR) expressed in euros per QALY
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Differences of quality of life in cancer patients between each group
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Differences of quality of life in myeloma patients between each group
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of participants with adverse events (AEs) and Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change from Baseline in Columbia-Suicide Severity Rating Scale (C-SSRS) Total Score at Day 15
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in The Clinician Administered Dissociative States Scale (CADSS) Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From pre-dosing in Modified Observer's Assessment of Alertness and Sedation (MOAA/S) Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of opioid medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Patient Reported Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Patient Reported Symptom Burden
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of successful same day discharge
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Adjustment disorder
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change to morning pre-dose FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Diagnostic delay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of previous psychiatric hospitalisations
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Degree of internal stigma
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Tolerability of the studied drug
Endpoint domain: Adverse events/effects
Primary endpoint: Gastric diseases detected
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Area under the NNC0480-0389 plasma concentration time curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brian Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in global Visual Analogic Scale (VAS) mean
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Volume and density of lipiodol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maturation rate of endo-Arterio venous fistula
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time to TOF > 0.9
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WHO bleeding events of Grade 2 or higher
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: No major adverse events within 30 days after operation
Endpoint domain: Adverse events/effects
Primary endpoint: Aortic dissection-related mortality
Endpoint domain: Mortality/survival
Primary endpoint: Reduction rate of AHRS scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Patient-Reported Pain Scores During Sexual Activity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in EEG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of postpartum contraception methods
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in episcleral venous blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in retinal blood flow in arterioles and venules
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Recurrence of endometrioma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: EORTC-QLQ-CR29
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percentage of patients with favorable functional outcome (score 0-2) according to Modified Rankin Scale (mRS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Relative change in extracellular resistance of the calf
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of change in weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Internalized Weight Bias
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Weight Self-Stigma
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Test-retest Reliability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Upper Extremity Trauma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of lung ultrasound in predicting fluid responsiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: sensitivity of non-physician graders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: specificity of non-physician graders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Participants with iPTH decrease >30%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: PET glucose measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: CEST-MRI glucose measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sensitivity and specificity of CEST-MRI glucose measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Repeatability of CEST-MRI glucose measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in fatigue scores
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Emotional Response
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: MS Work Difficulties Questionnaire-23
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Six-Minutes Walk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complicated post-operative course
Endpoint domain: Adverse events/effects
Primary endpoint: Child Behaviour
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prediction of mortality
Endpoint domain: Mortality/survival
Primary endpoint: Time to achieve a 1 point improvement in Patient's Global Impression of change (PGIC)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of programming related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Wound progress
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change From Baseline of Total Corneal Fluorescein Staining
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline of Ocular Discomfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean obstruction score at the tongue base
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Confirmed COVID-19 incidence in participants without evidence of past SARS-CoV-2 infection
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of participants with elevated troponin I levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Superiority with respect to neutralizing titers and noninferiority with respect to seroresponse rate of the anti-Omi immune response after 1 dose of BNT162b2 OMI compared to after 1 dose of BNT162b2 given as D3 in BNT162b2-experienced participants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Modified Grobman score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of pockets with PD ≥ 5 mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of Epstein-Barr Virus C Promoter Methylation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Specificity of Epstein-Barr Virus C Promoter Methylation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Kappa Value of Epstein-Barr Virus C Promoter Methylation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Protein levels in peri-implantitis and periodontitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postpartum Breastfeeding Self-Efficacy Scale-Short Form
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Semantic Difference Scale-Me as Mother
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Treatment Credibility and Expectancy Scale (CEQ-6) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Measurement of wrist flexor peak torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Measurement of wrist extensor peak torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Assessment of functional disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Measurement of hand grip strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Neuropathic Pain Scale (NPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Diagnosis of Liver Fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Parkinson's disease questionnaire (PDQ-8)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Coagulation grade 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Multiplexer residual volume <0.8
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum/muscle phosphorylated FAK
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: insulin receptor substrate 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gene expression of HIF-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum and muscle betaine concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: gene expression BGT-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gene expression MHC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of mitral valve insufficiency (regurgitation volume on MRI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Left atrial remodelling (left atrial volume on MRI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Presence and distribution patterns of LA fibrosis (quantification of fibrosis surface)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cerebral and renal oximetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cerebral and renal oximetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Gastrointestinal Distress
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Cytokine Panel 13
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Intraocular pressure reduction ≥ 20%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Invasive pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in number of minutes spent in aerobic exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in score on International Physical Activity Questionnaire Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in sleep efficiency at Week 15
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change from Baseline in agitation on the Cohen-Mansfield Agitation Inventory at Week 15
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline in depression on the Cornell Scale for Depression in Dementia at Week 15
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Diaphragmatic excursion in maximum inspiration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Geometric mean titre of antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean change in youth depression and anxiety symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean change in youth post traumatic stress disorder (PTSD) symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean change in youth self harming behaviors and suicidal ideation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean change in youth externalizing behaviors
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Volume of milk in stomach
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Gastric transit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Self-Care Power Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postpartum Quality of Life Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Edinburgh Postpartum Depression Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to stable infusion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence of grades III-IV acute GVHD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Vaccine hesitancy score (Opel score)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status